Hypertriglyceridemia during Long-Term Interferon-Alpha Therapy: Efficacy of Diet and Gemfibrosil Treatment. A Case Report

Interferon-alpha might increase triglyceride serum levels through the enhancement of hepatic lipogenesis and/or inhibition of the peripheral lipoprotein lipase. Hypertriglyceridemia during interferon-alpha therapy has been only recently described, mostly in patients with previous abnormalities of lipid metabolism. The authors report here a case of a 65-year-old male bearing advanced colon carcinoma who developed hypertriglyceridemia during long-term interferon-alpha treatment in association with 5 fluorouracil administration. Hypertriglyceridemia was maintained within acceptable levels, without adjusting the treatment plan, by an appropriate diet and gemfibrosil administration.

[1]  Jack Wang,et al.  Circulating interferon-α levels and hypertriglyceridemia in the acquired immunodeficiency syndrome , 1991 .

[2]  J. Wang,et al.  Circulating interferon-alpha levels and hypertriglyceridemia in the acquired immunodeficiency syndrome. , 1991, The American journal of medicine.

[3]  K. Feingold,et al.  Evidence for two classes of cytokines that stimulate hepatic lipogenesis: relationships among tumor necrosis factor, interleukin-1 and interferon-alpha. , 1990, Endocrinology.

[4]  S. Wadler,et al.  Clinical update on the role of fluorouracil and recombinant interferon alfa-2a in the treatment of colorectal carcinoma. , 1990, Seminars in oncology.

[5]  M. Serio,et al.  Multiple cytokines stimulate hepatic lipid synthesis in vivo. , 1989, Endocrinology.

[6]  C. Dinarello.  Interleukin-1 and its biologically related cytokines. , 1989, Advances in immunology.

[7]  A. Gotto,et al.  The hyperlipoproteinemias. , 1989, The Medical clinics of North America.

[8]  K. Öberg,et al.  Medical treatment of neuroendocrine gut and pancreatic tumors. , 1989, Acta oncologica.

[9]  B. Beutler,et al.  CACHECTIN: MORE THAN A TUMOR NECROSIS FACTOR , 1988 .

[10]  K. Feingold,et al.  Tumor necrosis factor-alpha stimulates hepatic lipogenesis in the rat in vivo. , 1987, The Journal of clinical investigation.

[11]  P. Pekala,et al.  Regulation of lipoprotein lipase synthesis and 3T3-L1 adipocyte metabolism by recombinant interleukin 1. , 1986, Biochimica et biophysica acta.

[12]  E. Borden,et al.  Effects of recombinant interferon-alpha 2 treatment upon lipid concentrations and lipoprotein composition. , 1986, Journal of interferon research.

[13]  B. Aggarwal,et al.  Interferons and tumor necrosis factors have similar catabolic effects on 3T3 L1 cells. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[14]  B. Beutler,et al.  Recombinant interleukin 1 suppresses lipoprotein lipase activity in 3T3-L1 cells. , 1985, Journal of immunology.

[15]  E. Borden,et al.  Decreases in serum high-density-lipoprotein cholesterol and total cholesterol resulting from naturally produced and recombinant DNA-derived leukocyte interferons. , 1984, Metabolism: clinical and experimental.

[16]  G. Steele,et al.  Cancer: Principles and Practice of Oncology , 1983 .

[17]  M. Landy,et al.  Interleukins, lymphokines, and cytokines : proceedings of the Third International Lymphokine Workshop , 1983 .

[18]  S. Grossberg,et al.  Interferon inhibits the conversion of 3T3-L1 mouse fibroblasts into adipocytes. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[19]  R. Lees,et al.  Effects of an experimental viral infection on plasma lipid and lipoprotein metabolism. , 1972, Metabolism: clinical and experimental.

[20]  W. Beisel,et al.  Infection with Diplococcus pneumoniae and Salmonella typhimurium in monkeys: changes in plasma lipids and lipoproteins. , 1972, The Journal of infectious diseases.

[21]  J. Gallin,et al.  Serum lipids in infection. , 1969, The New England journal of medicine.